mTOR may also serve as a convergence point between the acute antidepressant effects of ketamine and the longer-term prophylactic effects of lithium in bipolar disorder, since a key mechanism of the latter involves GSK3β inhibition, an upstream regulator of mTOR activity. The gene discussed is GSK3B; the disease is bipolar disorder.